1) Alper K, Schwartz KA, Kolts RL, et al:Seizure incidence in psychopharmacological clinical trials:An analysis of Food and Drug Administration(FDA)summary basis of approval reports. Biol Psychiatry 62:345-354, 2007
2) Giorgi FS, Pizzanelli C, Biagioni F, et al:The role of norepinephrine in epilepsy:From the bench to the bedside. Neurosci Biobehav Rev 28:507-524, 2004
3) 畑矢浩二,萬谷昭夫,辻誠一,他:Quetiapineによりけいれんが誘発された精神遅滞の1例.精神医学 49:1123-1126, 2007
4) Meltzer HY:The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21(2 Suppl):S106-S115, 1999
5) Richelson E, Souder T:Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci 68:29-39, 2000
6) Starr MS:The role of dopamine in epilepsy. Synapse 22:159-194, 1996
7) Watanabe K, Ashby CR, Katsumori H, et al:The effect of the acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 398:239-246, 2000
8) Yamamura S, Ohoyama K, Hamaguchi T, et al:Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex. Psychopharmacolology(Berl), 206:243-258, 2009
9) Yokota K, Tatebayashi H, Matsuo T, et al:The effects of neuroleptics on the GABA-induced Cl-current in rat dorsal root ganglion neurons:Differences between some neuroleptics. Br J Pharmacol 135:1547-1555, 2002